Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production

COVID-19 causes consequences such as imbalance of the immune system and thrombotic events. During the infection process, NETs in excess induce a pro-inflammatory response and disseminated intravascular coagulation. We evaluated the role of enoxaparin as a potential inhibitor of NETs. K18-hACE2 anima...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical immunology (Orlando, Fla.) Fla.), 2023-12, Vol.257, p.109836-109836, Article 109836
Hauptverfasser:	Córneo, Emily S, Veras, Flavio Protasio, Gomes, Giovanni F, Schneider, Ayda H, Manuella, Bruna, Almeida, Cicero J L R, Silva, Camila M, Martins, Ronaldo B, Batah, Sabrina S, Simon, Carla S, Prestes, Gabriele da S, Alves-Filho, José Carlos, Arruda, Eurico, Louzada-Junior, Paulo, de Oliveira, Renê D R, Fabro, Alexandre T, Cunha, Thiago M, Cunha, Fernando Queiroz, Dal-Pizzol, Felipe
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals COVID-19 Enoxaparin - pharmacology Extracellular Traps Humans Neutrophils SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!